METHOD OF TREATMENT USING LIPOSOMALLY FORMULATED REDUCED GLUTATHIONE TO COOPERATE WITH IL-10 TO MODULATE INFLAMMATORY RESPONSE TRIGGERED IN HIV+ AND TB IMMUNE-COMPROMISED DIABETIC PATIENTS
Your Energy Systems, LLC;Western University of Health Sciences
发明人:
Frederick Timothy Guilford,Vishwanath Venketaraman
申请号：
US15511516
公开号：
US20170281714A1
申请日:
2015.09.28
申请国别(地区):
US
年份:
2017
代理人:
摘要：
In the setting of chronic infection with a pathogen, the immune system must adapt to the ongoing presence of inflammatory responses driven by the pathogen in order to control the replication of the infecting agent at an acceptable level while limiting immune-mediated damage (immunopathology) (1). A complex interaction is required to accomplish this using a balance of immune related cytokines to stimulate and control the immune response. A particular formulation of reduced glutathione of high concentration in a liposome is proposed. In cooperation with the immune system, the liposomally formulated reduced glutathione according to the invention surprisingly achieves the balance between over-reduction of IL-10 and its necessary bodily function and signaling.
